tag > Biotech
-
Scientists Create 'Xenobots' -- Virtual Creatures Brought to Life (nytimes.com)
Strictly speaking, these life-forms do not have sex organs — or stomachs, brains or nervous systems. The one under the microscope consisted of about 2,000 living skin cells taken from a frog embryo. Bigger specimens, albeit still smaller than a millimeter-wide poppy seed, have skin cells and heart muscle cells that will begin pulsating by the end of the day. These are all programmable organisms called xenobots, the creation of which was revealed in a scientific paper in January, by Sam Kriegmana, Douglas Blackistonb, Michael Levinb, and Josh Bongarda,
A xenobot lives for only about a week, feeding on the small platelets of yolk that fill each of its cells and would normally fuel embryonic development. Because its building blocks are living cells, the entity can heal from injury, even after being torn almost in half. But what it does during its short life is decreed not by the ineffable frogginess etched into its DNA — which has not been genetically modified — but by its physical shape. And xenobots come in many shapes, all designed by roboticists in computer simulations, using physics engines similar to those in video games like Fortnite and Minecraft...
All of which makes xenobots amazing and maybe slightly unsettling — golems dreamed in silicon and then written into flesh. The implications of their existence could spill from artificial-intelligence research to fundamental questions in biology and ethics. "We are witnessing almost the birth of a new discipline of synthetic organisms," said Hod Lipson, a roboticist at the Columbia University who was not part of the research team. "I don't know if that's robotics, or zoology or something else."
An algorithm running for about 24 hours iterated through possible body shapes, after which the the two researchers tried "to sculpt cellular figurines that resembled those designs." They're now considering how the process might be automated with 3-D cell printers, and the Times ponders other future possibilities the researchers have hinted at for their Xenobots. ("Sweep up ocean microplastics into a larger, collectible ball? Deliver drugs to a specific tumor? Scrape plaque from the walls of our arteries?")
-
Combined DNA Index System (CODIS)
Since 1996, the Combined DNA Index System (CODIS) is the national DNA data-base of the USA, created and maintained by the Federal Bureau of Investigation(FBI). It combines forensic science and computer technology into a tool which enables federal, state, and local forensic laboratories to exchange and compare DNA profiles electronically.
In that way the CODIS STR loci help in linking serial violent crimes to each other and to identify the offenders. The DNA Identification Act of 1994 dignified the FBI’s authority to establish a National DNA Index System (NDIS) for law enforcement purposes. Across the USA, over 190 public law enforcement laboratories participate in NDIS. More than 90 forensic laboratories in more than 50 countries use the CODIS software for their own database initiatives.
Thirteen core STR loci were selected to be the basis of the future CODIS national database on November! 3-14, 1997, in STR Project meeting. Later, additional seven loci (D1S1656, D2S441, D2S1338, D10S1248, D12S391, D19S433,and D22S1045) were added to the CODIS core in 2015, which came to effect from January 2017.
Different countries employ different STR-based DNA-profiling systems, e.g., 20 core CODIS universal in North America, 17 loci system in the UK(DNA-17), and 18 loci system in Australia. CODIS STR loci DNA-profiling system is based on multiplex reactions which result in testing many STR regions at the same time.
Text from the book "DNA Fingerprinting: Advancements and Future Endeavors"
The following related text on DNA Profiling from Wikipedia
The U.S. Patriot Act of the United States provides a means for the U.S. government to get DNA samples from suspected terrorists. DNA information from crimes is collected and deposited into the CODIS database, which is maintained by the FBI. CODIS enables law enforcement officials to test DNA samples from crimes for matches within the database, providing a means of finding specific biological profiles associated with collected DNA evidence.
When a match is made from a national DNA databank to link a crime scene to an offender having provided a DNA sample to a database, that link is often referred to as a cold hit. A cold hit is of value in referring the police agency to a specific suspect but is of less evidential value than a DNA match made from outside the DNA Databank.
FBI agents cannot legally store DNA of a person not convicted of a crime. DNA collected from a suspect not later convicted must be disposed of and not entered into the database. In 1998, a man residing in the UK was arrested on accusation of burglary. His DNA was taken and tested, and he was later released. Nine months later, this man's DNA was accidentally and illegally entered in the DNA database.
-
Fears over covert DNA database (FT, 2008) (Unpaywalled)
Valuable intelligence on thousands of suspected terrorists risks being lost because of backlogs at a little-known US federal government database that processes DNA samples gathered in Iraq, Afghanistan and elsewhere. The unfinished work at the database – part of a classified intelligence partnership of military, intelligence and law enforcement agencies – has been referred to in public documents but has not been openly discussed by US government officials.
DNA profiling (Wikipedia)
DNA profiling (also called DNA fingerprinting) is the process of determining an individual's DNA characteristics. DNA analysis intended to identify a species, rather than an individual, is called DNA barcoding. DNA profiling is a forensic technique in criminal investigations, comparing criminal suspects' profiles to DNA evidence so as to assess the likelihood of their involvement in the crime. It is also used in parentage testing, to establish immigration eligibility, and in genealogical and medical research. DNA profiling has also been used in the study of animal and plant populations in the fields of zoology, botany, and agriculture.
-
Draper's Genetically Modified Cyborg DragonflEye Takes Flight (Spectrum IEEE)
In January, we wrote about a cybernetic micro air vehicle under development at Draper called DragonflEye. DragonflEye consists of a living, slightly modified dragonfly that carries a small backpack of electronics. The backpack interfaces directly with the dragonfly’s nervous system to control it, and uses tiny solar panels to harvest enough energy to power itself without the need for batteries.
-
Testing for dna…er… I mean, corona virus - by gizadeathstar
"However, that raises another less-obvious but still-implied question, and hence our high octane speculation of the day. The coupling of testing with sequencing companies suggests the possibility that the tests could include a covert DNA sampling itself, building up a large database. Indeed, perhaps the sequencing expertise was needed in a certain way, for if one suspected biowarfare were being carried out, one would want sample of patients' DNA to see what, if any, might be genetic markers for people taken ill with the virus. And that possibility suggests in turn yet another possibility. Perhaps, just perhaps, one of the objectives of the whole plandemic is to create a climate of opinion for massive testing (voluntary or otherwise), because the designers of the operation are looking for some particular "group" of "someones" not otherwise visible to the naked eye, but only detectable through genetic sequencing."
-
Who controls Gilead Sciences, the US pharmaceutical producing a COVID-19 treatment which was rapidly approved by NIH and praised by the WHO? Donald Rumsfeld was chair of the board and remains a top shareholder.
Recent Gilead News:
Might The Experimental Drug Remdesivir Work Against COVID-19? (NPR, 2020)
With a coronavirus vaccine at least a year away, some scientists are investigating existing medicines and compounds that might work as effective treatments. A drug called Remdesivir is now in the spotlight.
Why Is Everyone Talking About Gilead Sciences? (fool, 2020)
The big biotech has a drug that struck out on one super-contagious disease but could be the best option on the scene for treating another. Chinese health officials scrambled to begin two clinical studies evaluating remdesivir in treating patients with COVID-19, the disease caused by the novel coronavirus. Gilead provided the drug at no charge for these studies and gave input on how the studies should be designed and conducted. In late February 2020, the National Institutes for Health (NIH) began the first U.S. clinical trials of remdesivir in treating COVID-19. Gilead also initiated two late-stage clinical studies of its own in Asian countries and other countries with high numbers of COVID-19 cases in early March. World Health Organization assistant director-general Bruce Aylward even said that remdesivir is the "one drug right now that we think may have efficacy."
FDA chief highlights Gilead drug’s availability under compassionate use for Covid-19 (medcity, 2020)
In remarks at the daily Coronavirus Task Force press briefing, FDA Commissioner Stephen Hahn pointed out that the drug, remdesivir, is available under compassionate use in addition to the ongoing clinical trials being run by Gilead Sciences and the NIH.
Gilead Sciences Could Be the First to Beat the Coronavirus (Yahoo Finance, 2020)
Gilead Sciences Stock Price The coronavirus’ grip on the market continues. Since the beginning of February, the S&P 500 has shed 8.5% of its value, a reflection of the effect the outbreak is having on the global economy. Amidst the bloodbath, one specific group of stocks is holding up. These are the drug companies those infected, the public at large and investors are hoping can halt the virus from spreading any further. Gilead Sciences (GILD) is among those leading the search for a treatment and is currently being rewarded by the market. In contrast to the broader market, GILD stock is up 23% year-to-date.
Gilead puts emergency access to experimental coronavirus drug on hold amid surging demand (Retuers, 23.march.2010)
Gilead Sciences Inc said on Sunday it was temporarily putting new emergency access to its experimental coronavirus drug remdesivir on hold due to overwhelming demand and that it wanted most people receiving the drug to participate in a clinical trial to prove if it is safe and effective.
Enter the Donald:
Donald H. Rumsfeld Named Chairman of Gilead Sciences (Gilead, 1997)
Gilead Sciences Inc. (Nasdaq: GILD) today announced that board member Donald H. Rumsfeld will assume the position of Chairman, effective immediately. Mr. Rumsfeld succeeds Michael L. Riordan, M.D., who founded Gilead in 1987 and has served as Chairman since 1993. Dr. Riordan will continue to serve as a director on the board.
Gilead Sciences’s criminal drug testing: a cover for the Pentagon’s illegal arms testing? (voltairenet, 2018)
The company Gilead Sciences has deliberately carried on with testing Sovaldi (Sofosbuvir), its drug against Hepatitis C, in violation of international laws and without first obtaining its patients’ consent.
Donald_H._Rumsfeld and Gilead_Sciences (SourceWatch)
"Rummy was Chair of the Board of Directors at Gilead Sciences until named to the Bush cabinet and, like [Vice President Dick] Cheney, still has ties that bind to the 'old company.' Now isn't it an 'amazing coincidence' that the drug Tamiflu patented by Gilead Sciences is being pushed by the National Institutes of Allergies and Infectious Diseases as the NUMBER ONE choice for flu, which, wonder of wonders, is sweeping through in one epidemic after another," Free Market News related October 21, 2005, from a January 2004 web posting.
Donald Rumsfeld makes $5m killing on bird flu drug (independent, 2006)
Donald Rumsfeld has made a killing out of bird flu. The US Defence Secretary has made more than $5m (£2.9m) in capital gains from selling shares in the biotechnology firm that discovered and developed Tamiflu, the drug being bought in massive amounts by Governments to treat a possible human pandemic of the disease.
Donald Rumsfeld's controversial links to drug company behind Tamiflu (dailymail, 2009)
The drug company behind the swine flu medicine Tamiflu is at the centre of controversy over its links to former US Defence Secretary Donald Rumsfeld.
Rumsfeld's growing stake in Tamiflu (CNN, 2007)
Defense Secretary, ex-chairman of flu treatment rights holder, sees portfolio value growing.
Tamiflu and Donald Rumsfeld (Snoops)
Does Secretary of Defense Donald Rumsfeld own Tamiflu stock? Status: True.
Rumsfeld to Avoid Bird-Flu Drug Issues (NYTimes, 2006)
Defense Secretary Donald H. Rumsfeld has recused himself from government decisions concerning medications to prevent or treat avian flu, rather than sell his stock holdings in the company that patented the antiviral agent Tamiflu, according to a Pentagon memorandum issued Thursday. The memorandum, to Mr. Rumsfeld's staff from the Pentagon general counsel, said the defense secretary would not take part in decisions that may affect his financial interests in Gilead Sciences Inc. Before becoming defense secretary in January 2001, Mr. Rumsfeld was chairman of Gilead. On each of his annual financial disclosure statements, he has listed continued stock holdings in the company. Gilead holds the patent on Tamiflu, but contracts for it are signed with an American subsidiary of F. Hoffman-LaRoche Ltd., which holds marketing and manufacturing rights. Mr. Rumsfeld will remain involved in matters related to the Pentagon response to an outbreak, so long as none affect Gilead.
The Fight Against Monsanto's Roundup: The Politics of Pesticides (Book by Mitchel Cohen)
Gilead Science, Eugenics Mass Murder of the Poor (2014)
#Health #Biotech #Politics #Economics #Military #Cryptocracy
-
The next outbreak? We’re not ready - TEDTalk by Bill Gates (2015)
In his 2015 TED Talk titled "The Next Outbreak? We're Not Ready," Bill Gates predicting: "If anything kills over 10 million people in the next few decades, it's most likely to be a highly infectious virus rather than a war."
Meet the world’s most powerful doctor: Bill Gates (2017, Politico)
Over the past decade, the world’s richest man has become the World Health Organization’s second biggest donor, second only to the United States and just above the United Kingdom. This largesse gives him outsized influence over its agenda, one that could grow as the U.S. and the U.K. threaten to cut funding if the agency doesn’t make a better investment case.
“The foundation’s impact on the WHO is enormous,” said Garrett, of the Council on Foreign Relations. “If they weren’t there, if they walked away with their money, the deleterious impact would be profound, and everyone is all too aware of that.”
-
WHO expert: We need more testing to beat coronavirus (newscientist)
“To actually stop the virus, [China] had to do rapid testing of any suspect case, immediate isolation of anyone who was a confirmed or suspected case, and then quarantine the close contacts for 14 days so that they could figure out if any of them were infected,” Aylward told New Scientist in an exclusive interview. “Those were the measures that stopped transmission in China, not the big travel restrictions and lockdowns.”
-
Bill Gates Calls For National Tracking System For Coronavirus During Reddit AMA (forbes)
Bill Gates Meeting Jeffrey Epstein Question: "What changes are we going to have to make to how businesses operate to maintain our economy while providing social distancing?" Answer: "The question of which businesses should keep going is tricky. Certainly food supply and the health system. We still need water, electricity and the internet. Supply chains for critical things need to be maintained. Countries are still figuring out what to keep running. Eventually we will have some digital certificates to show who has recovered or been tested recently or when we have a vaccine who has received it." From Bill Gates' Reddit AMA
Recent Related News:
- Bill Gates Met With Jeffrey Epstein Many Times, Despite His Past (NYTimes)
- Bill Gates met with Jeffrey Epstein on numerous occasions: report (NYPost)
- Jeffrey Epstein Hoped to Seed Human Race With His DNA (NYTimes)
- Bill Gates had a closer relationship with Jeffrey Epstein than he admitted, The New York Times reports (The Verge)
- All the tech moguls who have been linked to Jeffrey Epstein after he became a convicted sex offender (Business Insider)
- Bill Gates refuses to reveal why he flew on Lolita Express with Jeffrey Epstein four years aftre his release from prison while he was still chairman of Microsoft (dailymail)
- ID2020 Alliance (ID2020) - Partnering for a path to digital identity (Microsoft) - ID2020: digital identity with blockchain and biometrics (Accenture)
- Invisible Ink Could Reveal whether Kids Have Been Vaccinated (Scientific American) - Quantum-dot tattoos hold vaccination record (Rice Uni)
- Rockefeller Foundation Scenario Planning Document (see page 18) (PDF download)
- Bill Gates Met With Jeffrey Epstein Many Times, Despite His Past (NYTimes)
-
YC graduate Genecis Bioindustries turns food waste into compostable plastics (techcrunch)
#Comment: The biotech industry continues their go-to "we must control and engineer life on all levels, or all die" narrative, under the implicit "Everything is IP & Money" paradigm . It illustrates, that the industry by and large still has not comprehended the power of "scaling out" systems , instead of the legacy "scaling up". In short, greedy control freaks disregarding the flexibility and resilience of natural ecosystems which have been evolutionary fine-tuned for aeons.
-
Chinese foreign ministry spokesman tweets claim US military brought coronavirus to Wuhan
Foreign ministry spokesman Zhao Lijian wrote on Twitter: “This is so astonishing that it changed many things I used to believe in.” Photo: AP Chinese foreign ministry spokesman Zhao Lijian took to Twitter on Friday to double down on an unproven claim that the US military brought the new coronavirus
to the central city of Wuhan, where the outbreak began.
Zhao urged his more than 287,000 followers in two tweets on Friday morning to widely share an allegation from a Canada-based conspiracy website that the coronavirus originated in the US rather than the Wuhan seafood market that is thought to be its source.
“This is so astonishing that it changed many things I used to believe in,” he wrote on his official account.
The posts which Zhao Lijian referenced in his tweet: Did The Virus Originate in the US? and Further Evidence that the Virus Originated in the US - both by Larry Romanoff / Global Research.
Appeal to UN by former iranian president Former Iranian President Mahmoud Ahmadinejad sent a letter to the United Nations promoting a conspiracy theory that COVID-19 is a biological weapon created in a laboratory. In the letter, he claimed COVID-19 is “a new weapon for establishing and/or maintaining [the] political and economic upper hand in the global arena.” He went on to say the flulike illness, which has infected tens of thousands, was “produced in laboratories” by the “warfare stock houses of biologic war belonging to world hegemonic powers.”
Coronavirus conspiracy theories: US and Chinese politicians rush in where experts fear to tread (SCMP)
A Chinese foreign ministry spokesman who promoted online theories about the origins of Covid-19 is the latest high-profile figure to make unverified claims. Beijing angered by US politicians who have characterised it as a ‘Chinese virus’ and Senator Tom Cotton’s suggestion it came from a lab in Wuhan
Diplomat David Stilwell delivers a ‘stern representation’ of the US government’s position to Cui Tiankai. Meeting in Washington follows Chinese foreign ministry spokesman’s insinuation that the US military brought the coronavirus to China
-
Moderna’s Coronavirus Vaccine Trial Set to Begin This Month (Bloomberg)
Moderna's Stock Price Human studies of Moderna Inc.’s experimental coronavirus vaccine are set to begin this month, positioning it to be first among a host of shots that companies are developing to fight the contagion. The Moderna product is moving very rapidly and will enter human trials “within a couple of weeks,” said Richard Hatchett, CEO of the Coalition for Epidemic Preparedness Innovations, a group overseeing development of shots against deadly infections. The estimated start of a trial of Moderna’s vaccine is March 19, according to a U.S. government website.
Moderna Inc. (Wikipedia)
From Investor Presentation and R&D Presentation Moderna, Inc. is a Cambridge, Massachusetts-based biotechnology company that is focused on drug discovery and drug development based on messenger RNA (mRNA). The company creates synthetic mRNA that can be injected into patients to help them create their own therapies. In October 2013, the Defense Advanced Research Projects Agency (DARPA) awarded Moderna a grant worth up to $24.6 million to research and develop its mRNA drug technology to fight infectious diseases and biological weapons.
Darpa Cranks Up Antibody Research to Stall Coronavirus (Wired)
Antibodies are proteins that the immune system creates to remove viruses and other foreign objects from the body. Vaccines work by stimulating the body’s own immune system to produce antibodies against an invading virus. Currently, there is no vaccine that can be used against the virus that causes Covid-19, although drug companies like Johnson & Johnson and Cambridge-based Moderna are working on developing them
DARPA Races To Create a "Firebreak" Treatment for the Coronavirus (Spectrum IEEE)
When DARPA launched its Pandemic Preparedness Platform (P3) program two years ago, the pandemic was theoretical. It seemed like a prudent idea to develop a quick response to emerging infectious diseases. Researchers working under the program sought ways to confer instant (but short-term) protection from a dangerous virus or bacteria. Today, as the novel coronavirus causes a skyrocketing number of COVID-19 cases around the world, the researchers are racing to apply their experimental techniques to a true pandemic playing out in real time.
Moderna (MRNA:US) Shareholders
Institutional investors purchased a net $16.2 million shares of MRNA during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 37.48% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Moderna CEO: Stéphane Bancel (videos) @sbancel
Stéphane Bancel has served as Moderna's Chief Executive Officer since October 2011 and as a member of Moderna’s board of directors since March 2011. Before joining the Company, Mr. Bancel served for five years as Chief Executive Officer of the French diagnostics company bioMérieux SA.
-
Amazon is secretly working on a cure for the common cold (cnbc)
Amazon is working on a cure for the common cold in a years-long, top secret effort called "Project Gesundheit," according to three people familiar with the effort... The team is hoping to develop a vaccine, but is exploring a variety of approaches to the problem. Internally, the effort is sometimes referred to as the "vaccine project....".
Amazon isn't the only organization throwing resources into a cure for the cold. Researchers at Stanford and the University of California are working on a new approach that involves temporarily disabling a single protein inside our cells. Researchers at the Chan Zuckerberg Biohub also chipped into the effort. The researchers behind that group said, in a statement, that they were close to a cure.
Why Bill Gates thinks gene editing and artificial intelligence could save the world (geekwire)
Bill Gates has been working on global health for 20 years, and today he told the nation’s premier scientific gathering that advances in A.I and gene editing could accelerate those improvements exponentially in the years ahead. “We have an opportunity with the advance of tools like artificial intelligence and gene-based editing technologies to build this new generation of health solutions so that they are available to everyone on the planet."
Millions more are being spent to find new ways fighting sickle-cell disease and HIV in humans. Gates said techniques now in development could leapfrog beyond the current state of the art for immunological treatments, which require the costly extraction of cells for genetic engineering, followed by the re-infusion of those modified cells in hopes that they’ll take hold.
-
Talk by Dr. Michael Fiddy - DARPA Defense Sciences Office (DSO)
Program Manager of the RadioBio Program: RadioBio aims to establish whether functional signaling via electromagnetic waves between biological cells exists and, if it does, to determine what mechanisms are involved and what information is being transferred.
-
Improved CRISPR gene drive solves problems of old tech (Cornell University, March 2020)
Gene drives use genetic engineering to create a desired mutation in a few individuals that then spreads via mating throughout a population in fewer than 10 generations. Now, a Cornell study, "A Toxin-Antidote CRISPR Gene Drive System for Regional Population Modification," published Feb. 27 in the journal Nature Communications, describes a new type of gene drive with the potential to delay resistance.
-
"We have tested SARS-CoV-2 isolated from a patient and found that camostat mesilate blocks entry of the virus into lung cells," says Markus Hoffmann, the lead author of the study. Camostat mesilate is a drug approved in Japan for use in pancreatic inflammation. "Our results suggest that camostat mesilate might also protect against COVID-19," says Markus Hoffmann. "This should be investigated in clinical trials."
-
Lenovo, Intel, BGI Genomics team up on viral genome analysis
Technology and life science healthcare experts from Intel and Lenovo will work together to support BGI researchers with big data analytical technologies and computing resources, so as to further advance the capabilities of its sequencing tools, and more effectively analyze the genomic characteristics of the novel coronavirus.
-
BGI Group - The Biggest Genomics Company in the World?
BGI is headquartered in Shenzhen, China and has more than 5,000 employees located in 47 labs, 30% outside of China. BGI Group is a Chinese genome sequencing company, headquartered in Shenzhen, Guangdong, China. BGI Group announced in 2020 that it will make genome sequencing cheaper, breaking the $100 barrier for the first time. The Shenzhen company says the low cost will be possible with an "extreme" DNA sequencing system that is capable of decoding the genomes of 100,000 people a year.
China National Genebank (site)
This is a nonprofit created in 2011 with funding from BGI and the Chinese government. Their mission is to capture and catalog human, plant, and animal species and they claim to have 80% of the finished large genome projects in the world. Capacity for 150m genomes a year.
GeneBank Vision Video - Stranger then any sci-fi movie
A tour to China's national gene bank (1h youtube video)
BGI Founders
Wang Jian (Chinese: 汪建; born 13 April 1954)
Wang Jian is Chairman and co-founder of the BGI Group (formerly Beijing Genomics Institute). He graduated in 1979 from Hunan Medical College and in 1986 graduated with a Master's in Integrated Medicines from the Beijing University of Chinese Medicine. From 1988 to 1994, he was a research fellow at the University of Texas, the University of Iowa and the University of Washington, working on cell proliferation and differentiation. After returning to China in 1994 to set up Jubilee Biotechnology, this provided much of the initial capital used to set up the Beijing Genomics Institute with Yang Huanming, Liu Siqi and Yu Jun in 1999 in order to engage in research contributing to the Human Genome Project. After this work he was involved in the sequencing of the rice genome, first Asian human reference genome and numerous other large-scale genomics projects. In 2003 he was involved in the efforts to sequence and contain the SARS coronavirus, meeting with Hu Jintao who praised BGI's contribution. In 2007 the Beijing Genomics Institute become just BGI when it was relocated to Shenzhen as "the first citizen-managed, non-profit research institution in China". As the largest shareholder in BGI's holding company, in 2019 his net worth was estimated by Forbes to be US$1.2 billion. In January 2020 he travelled to Wuhan to set up a situation room tackling the COVID-19 disease outbreak, helping coordinate the development of diagnostic tests and a 2000-sq-meter emergency detection laboratory built in 5 days. Devoted to fitness and believing health and longevity to be the first priority of BGI, he has climbed and skied on some of the highest mountains in the world, including summiting Mount Everest.
Yang Huanming (Chinese: 杨焕明; born 6 October 1952)
Yang Huanming is a Chinese biologist and businessman. one of China's leading genetics researchers. He is Chairman and co-founder of the Beijing Genomics Institute, formerly of the Chinese Academy of Sciences. He was elected as member of the Chinese Academy of Sciences in 2007, a foreign academician of Indian National Science Academy in 2009, a member of the German National Academy of Sciences in 2012, and foreign associate of the US National Academy of Science in 2014.
Yang Huanming: Sequencing Technology in Biomedicine
